Navigation Links
FREEDOM-M Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint
Date:6/6/2011

gement on a one-hour conference call to answer questions related to FREEDOM-M.

The conference call is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. A rebroadcast of the conference call will be available for two weeks and can be accessed by dialing 1-800-642-1687, with international callers dialing 1-706-645-9291, and using conference code: 72976350.

This conference call is also being webcast and can be accessed via our website at http://ir.unither.com/events.cfm.

About Tyvaso (treprostinil) Inhalation Solution

Indication

Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%).

The effects diminish over the minimum recommended dosing interval of 4 hours; treatment timing can be adjusted for planned activities.

While there are long-term data on use of treprostinil by other routes of administration, nearly all controlled clinical experience with inhaled treprostinil has been on a background of bosentan (an endothelin receptor antagonist) or sildenafil (a phosphodiesterase type 5 inhibitor).  The controlled clinical experience was limited to 12 weeks in duration.

Important Safety Information

  • TYVASO is intended for oral inhalation only. TYVASO is approved for use only with the TYVASO Inhalation System.
  • The safety and efficacy of TYVASO have not been established in patients with significant underlying lung disease (such as asthma or chronic obstructive pulmonary disease) and in patients under 18 years of age.  Patients with acute pulmona
    '/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Clinicient Inc , a leader ... results of an industry survey of how efficiently ... practice owners and administrative staff completed the brand-neutral ... technology and services that improve therapist efficiency. ... published a free 12-page guide to help physical ...
(Date:5/26/2015)... , May 26, 2015  EndoChoice today announced the ... of its common stock, which will represent 25.6% of ... Delaware corporation in connection with ... estimated to be between $15 and $17 per share. ... 30-day option to purchase up to an additional 937,500 ...
(Date:5/26/2015)... , May 26, 2015 ... technology,s commercial potential ,What,s the future of technologies ... commercial predictions from 2015. Stay ahead there for ... you explore sales results, R&D, opportunities and revenue ... visiongain shows you what,s possible for ...
Breaking Medicine Technology:Survey: Half of Physical Therapists Underbill For Their Services 2EndoChoice Announces Launch of Its Initial Public Offering 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7
(Date:5/26/2015)... Securityhunter has been awarded a ... States Department of Health and Human Services (HHS) through ... was awarded through the General Services Administration (GSA) Multiple ... which is a fee-for-service agency. The award is for ... is an enterprise–wide physical security and security system integration ...
(Date:5/26/2015)... Platte, LA (PRWEB) May 26, 2015 ... readers along with her as she writes an unforgettable ... difficult challenges in her life. The first black student ... was harassed and beaten by some students, treated harshly ... white woman. A motivating personal phone conversation with Dr. ...
(Date:5/26/2015)... Over 700 doctors, nutritionists, nurses, and ... the secretaries of the U.S. Department of Agriculture and ... them to embrace the 2015 Dietary Guidelines Advisory Committee’s ... human health, economic prosperity, and our nation’s food security. ... letter, including: Dr. David Katz, founding director of the ...
(Date:5/26/2015)... 26, 2015 The American College of Traditional ... for the Open House/Free Application Day on Wednesday, July 22. ... 4 p.m. and will be held at ACTCM Pioneer Square, ... After checking in, attendees will be greeted with an introduction ... of the campus at 11:45 a.m. Lunch will be served ...
(Date:5/26/2015)... Irwin Gross, M.D., Accumen, Inc.’s ... Patient Blood Management (PBM) initiative at Eastern Maine Medical ... by more than 60 percent and improved patient outcomes ... in an article in the May 2015 edition of ... red cell loss, less acute kidney injury and cut ...
Breaking Medicine News(10 mins):Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 3Health News:ACTCM to Host Summer Open House 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3
... - Patients with an implantable cardioverter defibrillator did not ... rhythms// or death by consuming fish oil supplements, which ... to a study in the June 14 issue of ... approximately 50 percent of all death from cardiovascular disease ...
... that the number of violent attacks on hospital staff ... According to the figures that were released by the ... had reported 224 incidents of violence, which is an ... represents the health workers, says that violence against staff ...
... of New Zealanders who take party pills in higher doses ... party pills escape people from taking drugs. ,Nearly ... atleast once – says researchers commissioned by the Ministry of ... parts such as sleeplessness, loss of appetite, strange thoughts and ...
... Prozac has been cleared for treating children over eight years ... its use//. ,The conditions imposed by the European ... only when other therapies have failed. "Prozac should only be ... therapy alone after four to six sessions," said the EMEA. ...
... Taking vitamin E supplements during pregnancy may lead to ... ,Vitamin E is an anti-oxidant found naturally in foods ... suggested that vitamin E, particularly taken with vitamin C, ... ,However, Andrew Shennan, who led a two-year study ...
... A report on the Journal of General Dentistry reveals ... bone cancer therapies are supposed //to take drugs that ... osteonecrosis of the jaws (a rotting of the jaw ... used to prevent and treat osteoporosis, multiple myeloma, Paget’s ...
Cached Medicine News:Health News:Fish Oil does not Appear to Protect Against Abnormal Heart Rhythms 2Health News:Violence Against NHS Staff On The Raise 2Health News:Drugs With Bisphosphonates Packs Osteonecrosis Risk 2
Used for retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
Used for directing a flexible tipped wire guide in the ureter. The angled tip allows passage of the catheter past a ureteral stone in preparation for E.S.W.L. Supplied sterile in peel-open packages. ...
These flexible stone retrieval devices are reusable, 3 Fr in diameter, with a working length of either 60 cm or 115 cm...
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
Medicine Products: